We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Soft Drink Consumption Tied to Diabetes

By HospiMedica International staff writers
Posted on 06 May 2013
A new study confirms that drinking a standard size can of soda daily is associated with an increased risk for diabetes.

Researchers at Imperial College London (United Kingdom) established a case-cohort study that included 12,403 incident type 2 diabetes cases and a stratified subcohort of 16,154 participants selected from eight European cohorts participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study; after exclusions, the final sample size included 11,684 incident cases and a sub-cohort of 15,374 participants. More...
The researchers used regression models and random-effects meta-analyses to estimate the association between consumption of juices, nectars, and soft drinks, and type 2 diabetes incidences.

The results showed that one 336 g daily increment in sugar-sweetened and artificially sweetened soft drink consumption was associated with a hazard ratio (HR) of 1.22 and 1.52, respectively, for type 2 diabetes. After further adjustment for energy intake and body mass index (BMI), the association of sugar-sweetened soft drinks with type 2 diabetes persisted, but the association of artificially sweetened soft drinks became statistically not significant, and juice and nectar consumption was not associated with type 2 diabetes incidence. The study was published in the April 2013 issue of Diabetologia.

“The observed association between sugar-sweetened soft drinks and diabetes in the present analysis is of similar magnitude as the association reported in a meta-analysis of eight prospective studies, which was based on 15,043 diabetes cases mostly from the USA,” concluded lead author Dora Romaguera-Bosch, PhD, MSc, and colleagues. “Whether BMI acts as a mediator or confounder and the magnitude of the effect of weight gain on these associations should be further assessed in studies with repeated measures of body weight.”

Related Links:

Imperial College London



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Ultrasound System
FUTUS LE
Exam Table
PF400
Radiology System
Riviera SPV AT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.